Merck
-
Germany's Merck to invest $338 million in new Asia-Pacific life science production center in Daejeon, South Korea
German science and technology giant Merck is investing $338 million (approx. €300 million) to build a new life science production center in Daejeon, South Korea. This facility marks Merck's largest li
-
Germany's Merck KGaA opened a new chip materials factory in South Korea on Thursday, expanding molybdenum production to meet demand for advanced memory chips.
German science and technology company Merck on Thursday opened a new semiconductor materials factory in Eumseong, North Chungcheong Province, South Korea, aiming to expand molybdenum production to mee
-
Moderna's shares surged on Monday ahead of the release of Phase III data for its mRNA cancer vaccine next month.
Moderna's stock surged on Monday after the biotechnology company confirmed it would release highly anticipated Phase III data for its experimental mRNA cancer vaccine next month. The vaccine is being
-
Merck stock surged 84% in the past year, outperforming S&P 500, but analysts question if its future beyond Keytruda is priced in too soon given its low profitability.
Merck's shares have climbed 84% over the last twelve months, significantly outpacing the S&P 500's 19.1% gain and making it a top performer among peers. However, its operational metrics, including a 4
-
Merck & Co. (MRK) stock is nearing its valuation limit due to slowing growth in its core oncology products, analysis indicates.
Merck & Co.'s stock price has surged 85.5% over the past 12 months, with its current price-to-sales (P/S) ratio reaching 5.7x, close to its decade-high of 5.9x. Analysis suggests that its core oncolog
-
Moderna's stock doubles on promising cancer-vaccine results
The vaccine candidate, developed with Merck, is an mRNA therapy paired with the cancer drug Keytruda. It helped melanoma patients live longer in a late-stage trial, marking the first Phase 3 data for
-
Germany's Merck to invest $338 million in new Asia-Pacific life science production center in Daejeon, South Korea
German science and technology giant Merck is investing $338 million (approx. €300 million) to build a new life science production center in Daejeon, South Korea. This facility marks Merck's largest li
-
Germany's Merck KGaA opened a new chip materials factory in South Korea on Thursday, expanding molybdenum production to meet demand for advanced memory chips.
German science and technology company Merck on Thursday opened a new semiconductor materials factory in Eumseong, North Chungcheong Province, South Korea, aiming to expand molybdenum production to mee
-
Moderna's shares surged on Monday ahead of the release of Phase III data for its mRNA cancer vaccine next month.
Moderna's stock surged on Monday after the biotechnology company confirmed it would release highly anticipated Phase III data for its experimental mRNA cancer vaccine next month. The vaccine is being
-
Merck stock surged 84% in the past year, outperforming S&P 500, but analysts question if its future beyond Keytruda is priced in too soon given its low profitability.
Merck's shares have climbed 84% over the last twelve months, significantly outpacing the S&P 500's 19.1% gain and making it a top performer among peers. However, its operational metrics, including a 4
-
Merck & Co. (MRK) stock is nearing its valuation limit due to slowing growth in its core oncology products, analysis indicates.
Merck & Co.'s stock price has surged 85.5% over the past 12 months, with its current price-to-sales (P/S) ratio reaching 5.7x, close to its decade-high of 5.9x. Analysis suggests that its core oncolog
-
Moderna's stock doubles on promising cancer-vaccine results
The vaccine candidate, developed with Merck, is an mRNA therapy paired with the cancer drug Keytruda. It helped melanoma patients live longer in a late-stage trial, marking the first Phase 3 data for
- No data
Merck
24H Trending
-
1
CoinDesk: Nasdaq futures up nearly 2%; Anthropic indicative quotes briefly 24% higher
-
2
Financial Times: Anthropic Discloses Activation of Measures Under 'Responsible Scaling Policy'
-
3
Laprophan has raised $223 million through an IPO on the Casablanca Stock Exchange, marking the largest fundraising deal by an African pharmaceutical company.
-
4
What is the total supply of Zilliqa? Introduction to ZIL Supply and Circulating Supply
-
5
What is AMAZINGTEAM coin, and what is its future development outlook?
-
6
What is the value of SDG token? Is SDG token a good long-term investment?
-
7
Al Jazeera to Iranian military: Three oil tankers reportedly struck by mines and caught fire on the eastern side of the Strait of Hormuz since this morning
-
8
Deltaone via Deutsche Bank: Expects the US dollar to strengthen in the first half of 2027 and remain at high levels throughout the year.
-
9
Which is Better to Mine: Ethereum vs. Bitcoin — Mechanism Evolution and Current Mining Landscape Analysis
-
10
Bloomberg: Zimbabwe Seeks Multilateral Bank Aid to Clear Arrears
Markets Today
Recommended Reading



